China
AASraw: A Premier API CDMO Partner for Global Pharmaceutical Innovation AASraw Biochemical Technology Co., Ltd. is a leading ISO9001-certified enterprise specializing in the customized development and manufacturing of Active Pharmaceutical Ingredients (APIs). As a dedicated CDMO (Contract Development and Manufacturing Organization), we provide a seamless value chain of services—from laboratory-scale R&D and pilot-plant testing to full-scale commercial manufacturing. Integrated CDMO Capabilities AASraw is built on a foundation of scientific excellence. Our core expertise lies in complex organic synthesis and process chemistry. We assist our global clients by optimizing synthetic routes, reducing production costs, and ensuring the highest yield and purity for their proprietary chemical entities. Our facility is designed to handle diverse chemical reactions, providing the flexibility needed to meet specific project requirements at any stage of the product lifecycle. Advanced Infrastructure and Quality Assurance Quality is the cornerstone of our operations. AASraw operates a 500-square-meter R&D laboratory and a modern manufacturing facility that adheres strictly to GMP (Good Manufacturing Practice) guidelines. To ensure the integrity of our CDMO services, we utilize advanced analytical instrumentation, including: High-Performance Liquid Chromatography (HPLC) Gas Chromatography (GC) Liquid Chromatography-Mass Spectrometry (LC-MS) Our rigorous Quality Control (QC) and Quality Assurance (QA) protocols ensure that every process is documented, traceable, and compliant with international regulatory standards. Commitment to Partnership At AASraw, we view ourselves as an extension of our clients' R&D and manufacturing teams. We understand the importance of intellectual property protection and professional documentation. By providing comprehensive COAs (Certificates of Analysis) and technical data packages, we empower pharmaceutical companies and research institutions to achieve their commercial goals with confidence and efficiency. For more information on our manufacturing capabilities, please visit: www.aasraw.co
Stay updated on pharma trends and marketplace opportunities.